2012 Q3 Form 10-Q Financial Statement

#000088616312000060 Filed on November 14, 2012

View on sec.gov

Income Statement

Concept 2012 Q3 2012 Q1 2011 Q4
Revenue $6.375M $5.636M $12.94M
YoY Change 11.04% 44.66% 228.35%
Cost Of Revenue $683.0K $155.0K $2.060M
YoY Change -2.84% -70.75%
Gross Profit $5.692M $5.481M $10.88M
YoY Change 12.98% 62.64% 176.14%
Gross Profit Margin 89.29% 97.25% 84.1%
Selling, General & Admin $4.310M $3.420M $3.720M
YoY Change 8.84% -0.87% 7.2%
% of Gross Profit 75.72% 62.4% 34.19%
Research & Development $2.647M $2.817M $2.600M
YoY Change 7.12% 41.56% -17.72%
% of Gross Profit 46.5% 51.4% 23.9%
Depreciation & Amortization $638.0K $678.0K $700.0K
YoY Change -14.13% 13.0% 600.0%
% of Gross Profit 11.21% 12.37% 6.43%
Operating Expenses $2.647M $2.817M $5.880M
YoY Change 7.12% -43.66% -5.01%
Operating Profit -$1.425M -$839.0K $5.000M
YoY Change -56.14% -48.53% -322.22%
Interest Expense $735.0K $701.0K -$720.0K
YoY Change 5.15% -279.74% -2500.0%
% of Operating Profit -14.4%
Other Income/Expense, Net $1.373M $66.00K $860.0K
YoY Change -251.38% -102.95% -80.18%
Pretax Income -$52.00K -$773.0K $4.990M
YoY Change -98.75% -81.19% -413.84%
Income Tax $142.0K -$35.00K $300.0K
% Of Pretax Income 6.01%
Net Earnings -$194.0K $1.133M $4.690M
YoY Change -95.36% -88.23% 4.22%
Net Earnings / Revenue -3.04% 20.1% 36.25%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01 $57.33K $237.2K
COMMON SHARES
Basic Shares Outstanding 19.92B shares 19.71B shares 19.68M shares
Diluted Shares Outstanding 19.92B shares 19.74B shares 19.74M shares

Balance Sheet

Concept 2012 Q3 2012 Q1 2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.000M $11.30M $17.00M
YoY Change -43.09% -31.52% -25.11%
Cash & Equivalents $7.046M $9.777M $7.041M
Short-Term Investments $0.00 $1.500M $10.00M
Other Short-Term Assets $1.015M $1.300M $1.344M
YoY Change -59.4% 30.0% 124.0%
Inventory $2.548M $1.300M $1.301M
Prepaid Expenses $889.0K $905.0K
Receivables $2.200M $2.000M $6.100M
Other Receivables $4.500M $7.600M $6.300M
Total Short-Term Assets $17.43M $23.50M $32.23M
YoY Change -34.95% -24.92% -12.89%
LONG-TERM ASSETS
Property, Plant & Equipment $853.0K $400.0K $455.0K
YoY Change 21.86% -50.0% -24.17%
Goodwill $12.24M $12.24M
YoY Change
Intangibles $56.58M $58.33M
YoY Change
Long-Term Investments
YoY Change
Other Assets $416.0K $1.900M $738.0K
YoY Change -80.19% -40.63% -66.45%
Total Long-Term Assets $80.07M $86.50M $88.35M
YoY Change -16.94% -16.34% 128.89%
TOTAL ASSETS
Total Short-Term Assets $17.43M $23.50M $32.23M
Total Long-Term Assets $80.07M $86.50M $88.35M
Total Assets $97.51M $110.0M $120.6M
YoY Change -20.86% -18.34% 59.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.027M $7.900M $11.07M
YoY Change -40.33% -39.23% 28.66%
Accrued Expenses $5.381M $4.100M $5.054M
YoY Change -28.25% -65.55% -48.95%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.500M $10.00M
YoY Change -100.0% -70.0%
Long-Term Debt Due $13.30M $4.600M $3.200M
YoY Change
Total Short-Term Liabilities $29.88M $27.20M $43.64M
YoY Change -29.7% -39.01% 30.28%
LONG-TERM LIABILITIES
Long-Term Debt $17.90M $26.40M $20.30M
YoY Change -11.39% 32.0%
Other Long-Term Liabilities $403.0K $35.50M $388.0K
YoY Change -99.12% -33.4% -98.98%
Total Long-Term Liabilities $403.0K $61.90M $388.0K
YoY Change -99.39% -15.55% -98.98%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.88M $27.20M $43.64M
Total Long-Term Liabilities $403.0K $61.90M $388.0K
Total Liabilities $76.27M $91.50M $104.1M
YoY Change -31.78% -24.25% 44.32%
SHAREHOLDERS EQUITY
Retained Earnings -$683.8M -$682.2M
YoY Change
Common Stock $21.00K $21.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $42.28M $42.28M $42.28M
YoY Change
Treasury Stock Shares 1.118M shares 1.118M shares
Shareholders Equity $21.24M $18.50M $8.185M
YoY Change
Total Liabilities & Shareholders Equity $97.51M $110.0M $120.6M
YoY Change -20.86% -18.34% 59.5%

Cashflow Statement

Concept 2012 Q3 2012 Q1 2011 Q4
OPERATING ACTIVITIES
Net Income -$194.0K $1.133M $4.690M
YoY Change -95.36% -88.23% 4.22%
Depreciation, Depletion And Amortization $638.0K $678.0K $700.0K
YoY Change -14.13% 13.0% 600.0%
Cash From Operating Activities -$900.0K -$369.0K $7.000M
YoY Change -18.18% -141.0% -638.46%
INVESTING ACTIVITIES
Capital Expenditures -$300.0K $19.00K $0.00
YoY Change 200.0%
Acquisitions $4.300M $2.000M
YoY Change
Other Investing Activities -$2.000M $4.000M -$2.400M
YoY Change -117.24% -340.0%
Cash From Investing Activities -$2.400M $3.945M -$2.200M
YoY Change 1100.0% -117.0% -320.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $2.600M
YoY Change
Debt Paid & Issued, Net $8.500M
YoY Change
Cash From Financing Activities 1.500M -$840.0K 100.0K
YoY Change -103.37% -150.0%
NET CHANGE
Cash From Operating Activities -900.0K -$369.0K 7.000M
Cash From Investing Activities -2.400M $3.945M -2.200M
Cash From Financing Activities 1.500M -$840.0K 100.0K
Net Change In Cash -1.800M $2.736M 4.900M
YoY Change 38.46% 5.23% -1080.0%
FREE CASH FLOW
Cash From Operating Activities -$900.0K -$369.0K $7.000M
Capital Expenditures -$300.0K $19.00K $0.00
Free Cash Flow -$600.0K -$388.0K $7.000M
YoY Change -40.0% -143.11% -638.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2011Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
127000 USD
CY2012Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
124000 USD
CY2011Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11065000 USD
CY2012Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6027000 USD
CY2011Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5054000 USD
CY2012Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5381000 USD
CY2011Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
355000 USD
CY2012Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
485000 USD
CY2011Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4771000 USD
CY2012Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4800000 USD
CY2011Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
732676000 USD
CY2012Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
747316000 USD
CY2012Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
1013000 USD
CY2011Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
950000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
3116000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2646000 USD
CY2012Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
CY2011Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1700000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1900000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1600000 shares
CY2011Q4 us-gaap Assets
Assets
120583000 USD
CY2012Q3 us-gaap Assets
Assets
97506000 USD
CY2012Q3 us-gaap Assets Current
AssetsCurrent
17434000 USD
CY2011Q4 us-gaap Assets Current
AssetsCurrent
32230000 USD
CY2012Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1341000 USD
CY2011Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
11341000 USD
CY2011Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
11341000 USD
CY2012Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1341000 USD
CY2012Q3 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
USD
CY2011Q4 us-gaap Available For Sale Securities Gross Unrealized Losses1
AvailableForSaleSecuritiesGrossUnrealizedLosses1
USD
CY2012Q3 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
USD
CY2011Q4 us-gaap Availableforsale Securities Gross Unrealized Gain
AvailableforsaleSecuritiesGrossUnrealizedGain
USD
CY2011Q1 us-gaap Business Acquisition Contingent Consideration At Fair Value Current
BusinessAcquisitionContingentConsiderationAtFairValueCurrent
17600000 USD
CY2011Q1 us-gaap Business Acquisition Cost Of Acquired Entity Cash Paid
BusinessAcquisitionCostOfAcquiredEntityCashPaid
31600000 USD
us-gaap Business Acquisitions Pro Forma Income Loss From Continuing Operations Before Changes In Accounting And Extraordinary Items Net Of Tax
BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax
-5549000 USD
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
4886000 USD
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
17290000 USD
CY2012Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
2093000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
-1317000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
1191000 USD
CY2011Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High
BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh
-198000 USD
us-gaap Business Exit Costs
BusinessExitCosts
159000 USD
us-gaap Business Exit Costs
BusinessExitCosts
-168000 USD
CY2011Q3 us-gaap Business Exit Costs
BusinessExitCosts
-2000 USD
CY2012Q3 us-gaap Business Exit Costs
BusinessExitCosts
-15000 USD
CY2012Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7046000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7041000 USD
CY2011Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2251000 USD
CY2010Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3346000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1095000 USD
CY2012Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000000 USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
USD
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-550000 USD
CY2011Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
33333333 shares
CY2011Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
33333333 shares
CY2011Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20682506 shares
CY2012Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21082678 shares
CY2012Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21082678 shares
CY2011Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20682506 shares
CY2012Q3 us-gaap Common Stock Value
CommonStockValue
21000 USD
CY2011Q4 us-gaap Common Stock Value
CommonStockValue
21000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4998000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1590000 USD
CY2011Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4178000 USD
CY2012Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-194000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentrations of Credit Risk</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash equivalents and investments and accounts receivable.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invests its excess cash principally in United States government debt securities, investment grade corporate debt securities and certificates of deposit. The Company has established guidelines relative to diversification and maturities that maintain safety and liquidity. These guidelines are periodically reviewed and modified to take advantage of trends in yields and interest rates. The Company has not experienced any significant losses on its cash equivalents, short-term investments or restricted investments for the periods ending </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2011</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2011</font><font style="font-family:inherit;font-size:10pt;">, cash deposits held at financial institutions in excess of FDIC insured amounts of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$250,000</font><font style="font-family:inherit;font-size:10pt;"> were approximately </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$6.8 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$13.1 million</font><font style="font-family:inherit;font-size:10pt;">, respectively.</font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounts receivable from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">one</font><font style="font-family:inherit;font-size:10pt;"> customer was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">60%</font><font style="font-family:inherit;font-size:10pt;"> and accounts receivable from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">two</font><font style="font-family:inherit;font-size:10pt;"> customers was </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">67%</font><font style="font-family:inherit;font-size:10pt;"> of total accounts receivable at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2011</font><font style="font-family:inherit;font-size:10pt;">, respectively.&#160; </font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company currently obtains Captisol from a sole-source supplier.&#160; If this supplier was not able to supply the requested amounts of Captisol, the Company would be unable to continue to derive revenues from the sale of Captisol until it obtained an alternative source, which might take a considerable length of time.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>
CY2012Q3 us-gaap Contractual Obligation
ContractualObligation
21517000 USD
CY2012Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
683000 USD
CY2011Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
703000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
1273000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2851000 USD
CY2011Q4 us-gaap Deferred Revenue
DeferredRevenue
1200000 USD
CY2012Q3 us-gaap Deferred Revenue
DeferredRevenue
900000 USD
CY2011Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1240000 USD
CY2012Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
458000 USD
CY2012Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2538000 USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
3000 USD
CY2011Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3466000 USD
CY2011Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
237000 USD
CY2012Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
237000 USD
CY2012Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2662000 USD
CY2011Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
2230000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2099000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1978000 USD
CY2011Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
743000 USD
CY2012Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
638000 USD
CY2012Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
USD
us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
3670000 USD
CY2011Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Net Of Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
USD
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
14000 USD
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
USD
CY2012Q3 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
USD
us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
-14000 USD
CY2011Q3 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
USD
CY2012Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2011Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.26
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2012Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1157000 USD
CY2011Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1806000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3925000 USD
CY2011Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2179000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2300000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
2300000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2300000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2300000 USD
CY2012Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2300000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11261000 USD
CY2011Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3962000 USD
CY2012Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4382000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11824000 USD
CY2011Q4 us-gaap Goodwill
Goodwill
12238000 USD
CY2012Q3 us-gaap Goodwill
Goodwill
12238000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
5026000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-455000 USD
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-5260000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-4178000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-194000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4815000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-8546000 USD
CY2012Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-52000 USD
CY2011Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4156000 USD
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.27
CY2012Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
0.26
CY2011Q3 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.21
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
3670000 USD
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
USD
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
3000 USD
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
0.19
CY2011Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
CY2012Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare
us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
-13572000 USD
CY2012Q3 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
142000 USD
us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
445000 USD
CY2011Q3 us-gaap Income Tax Expense Benefit Continuing Operations
IncomeTaxExpenseBenefitContinuingOperations
22000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
27000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
15000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7110000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3009000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1246000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-476000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3953000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-446000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
13905000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1710000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
798000 USD
CY2012Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
56580000 USD
CY2011Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
58326000 USD
CY2012Q3 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
68818000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-566000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-322000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
15000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4129000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-4545000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-329000 USD
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
37406 shares
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2011Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2012Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0 shares
CY2011Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
70564000 USD
us-gaap Interest Expense
InterestExpense
1762000 USD
us-gaap Interest Expense
InterestExpense
2460000 USD
CY2012Q3 us-gaap Interest Expense
InterestExpense
838000 USD
CY2011Q3 us-gaap Interest Expense
InterestExpense
699000 USD
us-gaap Interest Paid
InterestPaid
1749000 USD
us-gaap Interest Paid
InterestPaid
1854000 USD
CY2012Q3 us-gaap Inventory Net
InventoryNet
2548000 USD
CY2011Q4 us-gaap Inventory Net
InventoryNet
1301000 USD
CY2011Q4 us-gaap Liabilities
Liabilities
104054000 USD
CY2012Q3 us-gaap Liabilities
Liabilities
76271000 USD
CY2012Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
97506000 USD
CY2011Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120583000 USD
CY2011Q4 us-gaap Liabilities Current
LiabilitiesCurrent
43643000 USD
CY2012Q3 us-gaap Liabilities Current
LiabilitiesCurrent
29879000 USD
CY2012Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
10000000 USD
CY2012Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
USD
CY2011Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
10000000 USD
CY2011Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
20286000 USD
CY2012Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
17876000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
681000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29947000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1335000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22853000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2011000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8189000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1461000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-8189000 USD
CY2012Q3 us-gaap Net Income Loss
NetIncomeLoss
-194000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1590000 USD
us-gaap Net Income Loss
NetIncomeLoss
5029000 USD
CY2011Q3 us-gaap Net Income Loss
NetIncomeLoss
-4178000 USD
CY2012Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1270000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3005000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-997000 USD
CY2011Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-907000 USD
CY2012Q3 us-gaap Notes Payable Current
NotesPayableCurrent
10272000 USD
CY2011Q4 us-gaap Notes Payable Current
NotesPayableCurrent
USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
21571000 USD
CY2011Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
9416000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
23919000 USD
CY2012Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
7697000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5541000 USD
CY2012Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1322000 USD
CY2011Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3249000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-3818000 USD
CY2012Q3 us-gaap Operating Leases Future Minimum Payments Due Future Minimum Sublease Rentals
OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals
17563000 USD
CY2011Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2893000 USD
CY2012Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3739000 USD
CY2011Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1344000 USD
CY2012Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1015000 USD
CY2012Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
416000 USD
CY2011Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
738000 USD
CY2011Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-31000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
USD
CY2012Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
USD
CY2011Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
388000 USD
CY2012Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
403000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
-135000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-201000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-348000 USD
CY2012Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
74000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
272000 USD
CY2011Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-10000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
59000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
55000 USD
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
USD
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
32024000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
300000 USD
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4300000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3500000 USD
CY2011Q4 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
116000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
633000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
10000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
USD
CY2012Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
889000 USD
CY2011Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
905000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3181000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
30000000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
7500000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
19346000 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
10000000 USD
CY2012Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5653000 USD
CY2011Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5226000 USD
CY2011Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
455000 USD
CY2012Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
853000 USD
CY2012Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
2157000 USD
CY2011Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
6110000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
USD
CY2011Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2471000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8315000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7693000 USD
CY2012Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2647000 USD
CY2012Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
USD
CY2011Q3 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2282000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2282000 USD
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
USD
CY2011Q4 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1341000 USD
CY2012Q3 us-gaap Restricted Cash And Investments Noncurrent
RestrictedCashAndInvestmentsNoncurrent
1341000 USD
CY2011Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-682232000 USD
CY2012Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-683822000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
9256000 USD
us-gaap Revenue Recognition Services Royalty Fees
RevenueRecognitionServicesRoyaltyFees
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Sale of Royalty Rights</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company previously sold to third parties the rights to future royalties of certain of its products. As part of the underlying royalty agreements, the partners have the right to offset a portion of any future royalty payments owed to the Company to the extent of previous milestone payments. Accordingly, the Company deferred a portion of the revenue associated with each tranche of royalty right sold, equal to the pro-rata share of the potential royalty offset. Such amounts associated with the offset rights against future royalty payments will be recognized as revenue upon receipt of future royalties from the respective partners. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December&#160;31, 2011</font><font style="font-family:inherit;font-size:10pt;">, the Company had deferred </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.9 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.2 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, of revenue related to the sale of royalty rights. As of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">September&#160;30, 2012</font><font style="font-family:inherit;font-size:10pt;">, </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.4 million</font><font style="font-family:inherit;font-size:10pt;"> is included in current portion of deferred revenue and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.5 million</font><font style="font-family:inherit;font-size:10pt;"> is included in long-term portion of deferred revenue.</font></div></div>
CY2011Q3 us-gaap Revenues
Revenues
5741000 USD
us-gaap Revenues
Revenues
17753000 USD
CY2012Q3 us-gaap Revenues
Revenues
6375000 USD
us-gaap Revenues
Revenues
17101000 USD
CY2011Q3 us-gaap Royalty Revenue
RoyaltyRevenue
2431000 USD
CY2012Q3 us-gaap Royalty Revenue
RoyaltyRevenue
3213000 USD
us-gaap Royalty Revenue
RoyaltyRevenue
6597000 USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
1277000 USD
CY2012Q3 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
USD
us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
USD
CY2011Q3 us-gaap Sale Leaseback Transaction Current Period Gain Recognized
SaleLeasebackTransactionCurrentPeriodGainRecognized
426000 USD
CY2011Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1679000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4150000 USD
CY2012Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1818000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
5713000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2646000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3116000 USD
CY2012Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
8300000 USD
CY2012Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
shares
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.69
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.69
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.69
CY2011Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.017
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.010
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.008
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
781738 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
16.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
13481 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
83374 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
710345 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1489000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1712737 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1146046 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.61
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.84
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
6729000 USD
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1712737 shares
CY2012Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
14.77
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.96
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
39.73
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
10.69
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
14.73
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M20D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2011Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M20D
CY2012Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2983000 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y11M16D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y1M21D
CY2012Q3 us-gaap Short Term Investments
ShortTermInvestments
USD
CY2011Q4 us-gaap Short Term Investments
ShortTermInvestments
10000000 USD
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
46799 shares
CY2012Q3 us-gaap Stockholders Equity
StockholdersEquity
21235000 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
8185000 USD
CY2011Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
8344000 USD
CY2012Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
USD
CY2011Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
112371 shares
CY2011Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
112371 shares
CY2011Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1118222 shares
CY2012Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
shares
CY2012Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1118222 shares
CY2012Q3 us-gaap Treasury Stock Value
TreasuryStockValue
42280000 USD
CY2011Q4 us-gaap Treasury Stock Value
TreasuryStockValue
42280000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:60px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and liabilities, at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company&#8217;s critical accounting policies are those that are both most important to the Company&#8217;s financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results may materially vary from these estimates.</font></div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19791793 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19686353 shares
CY2012Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19917676 shares
CY2011Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19673160 shares
CY2012Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19917676 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19648947 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19791793 shares
CY2011Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
19673160 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19791793 shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19673160 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19917676 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19648947 shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
37406 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
shares
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
shares
CY2011Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
shares
lgnd Additional Percentage Of Contingent Consideration
AdditionalPercentageOfContingentConsideration
0.1
CY2012Q3 lgnd Advanced Manufacturing Payments
AdvancedManufacturingPayments
2000 USD
CY2011Q4 lgnd Advanced Manufacturing Payments
AdvancedManufacturingPayments
312000 USD
CY2012Q3 lgnd Amount Included In Current Portion Of Deferred Revenue
AmountIncludedInCurrentPortionOfDeferredRevenue
400000 USD
CY2012Q3 lgnd Amount Included In Long Term Portion Of Deferred Revenue
AmountIncludedInLongTermPortionOfDeferredRevenue
500000 USD
lgnd Amount Of Related Revenue Current
AmountOfRelatedRevenueCurrent
15000000 USD
lgnd Amount Of Revenue For Contingent Consideration
AmountOfRevenueForContingentConsideration
15000000 USD
CY2012Q3 lgnd Business Acquisition Contingent Consideration Potential Cash Payment At End Of Period
BusinessAcquisitionContingentConsiderationPotentialCashPaymentAtEndOfPeriod
7600000 USD
CY2012Q3 lgnd Cash Deposits In Excess Of Fdic Insured Amount
CashDepositsInExcessOfFdicInsuredAmount
6800000 USD
CY2011Q4 lgnd Cash Deposits In Excess Of Fdic Insured Amount
CashDepositsInExcessOfFdicInsuredAmount
13100000 USD
CY2012Q3 lgnd Co Promote Termination Liability Current
CoPromoteTerminationLiabilityCurrent
4431000 USD
CY2011Q4 lgnd Co Promote Termination Liability Current
CoPromoteTerminationLiabilityCurrent
6197000 USD
CY2012Q3 lgnd Co Promote Termination Liability Noncurrent
CoPromoteTerminationLiabilityNoncurrent
8644000 USD
CY2011Q4 lgnd Co Promote Termination Liability Noncurrent
CoPromoteTerminationLiabilityNoncurrent
15255000 USD
CY2011Q4 lgnd Co Promote Termination Payments Receivable Current
CoPromoteTerminationPaymentsReceivableCurrent
6197000 USD
CY2012Q3 lgnd Co Promote Termination Payments Receivable Current
CoPromoteTerminationPaymentsReceivableCurrent
4431000 USD
CY2012Q3 lgnd Co Promote Termination Payments Receivable Noncurrent
CoPromoteTerminationPaymentsReceivableNoncurrent
8644000 USD
CY2011Q4 lgnd Co Promote Termination Payments Receivable Noncurrent
CoPromoteTerminationPaymentsReceivableNoncurrent
15255000 USD
lgnd Co Promotion Agreement Termination Assumed Payments Made By Assignee
CoPromotionAgreementTerminationAssumedPaymentsMadeByAssignee
2533000 USD
lgnd Co Promotion Agreement Termination Fair Value Adjustments
CoPromotionAgreementTerminationFairValueAdjustments
5844000 USD
CY2012Q3 lgnd Co Promotion Agreement Termination Liability
CoPromotionAgreementTerminationLiability
13075000 USD
CY2011Q4 lgnd Co Promotion Agreement Termination Liability
CoPromotionAgreementTerminationLiability
21452000 USD
CY2012Q3 lgnd Co Promotion Agreement Termination Liability Current
CoPromotionAgreementTerminationLiabilityCurrent
4431000 USD
CY2012Q3 lgnd Co Promotion Agreement Termination Liability Noncurrent
CoPromotionAgreementTerminationLiabilityNoncurrent
8644000 USD
lgnd Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
4347000 USD
lgnd Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
4791000 USD
CY2012Q3 lgnd Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
1344000 USD
CY2011Q3 lgnd Collaborative Research And Development And Other Revenues
CollaborativeResearchAndDevelopmentAndOtherRevenues
1631000 USD
CY2011Q1 lgnd Companies Supported To Drug Development Efforts
CompaniesSupportedToDrugDevelopmentEfforts
40 company
CY2011Q1 lgnd Contingent Liability Accrual Discount Rate
ContingentLiabilityAccrualDiscountRate
0.216
CY2012Q3 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
323000 USD
CY2011Q4 lgnd Current Portion Of Liability For Contingent Value Rights
CurrentPortionOfLiabilityForContingentValueRights
6879000 USD
lgnd Date Of Settlement Agreement
DateOfSettlementAgreement
April 1996
CY2011Q4 lgnd Deposits Liabilities Noncurrent
DepositsLiabilitiesNoncurrent
388000 USD
CY2012Q3 lgnd Deposits Liabilities Noncurrent
DepositsLiabilitiesNoncurrent
284000 USD
CY1996Q2 lgnd Exchange Ratio Of Common Shares Related To Legal Settlement
ExchangeRatioOfCommonSharesRelatedToLegalSettlement
74.25
CY2012Q3 lgnd Finite Lived Intangible Assets Gross Including Goodwill
FiniteLivedIntangibleAssetsGrossIncludingGoodwill
72743000 USD
CY2011Q4 lgnd Finite Lived Intangible Assets Gross Including Goodwill
FiniteLivedIntangibleAssetsGrossIncludingGoodwill
72743000 USD
lgnd Lease Expiration Year Maximum
LeaseExpirationYearMaximum
2019
lgnd Lease Expiration Year Minimum
LeaseExpirationYearMinimum
2014
CY2011Q4 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
10419000 USD
CY2012Q3 lgnd Liability For Contingent Value Rights
LiabilityForContingentValueRights
7735000 USD
lgnd Limit Of Revenue For Contingent Consideration For Additional Percentage
LimitOfRevenueForContingentConsiderationForAdditionalPercentage
35000000 USD
CY2012Q3 lgnd Line Of Credit Facility Additional Payment On Borrowings Percentage
LineOfCreditFacilityAdditionalPaymentOnBorrowingsPercentage
0.06
CY2012Q3 lgnd Long Term Portion Of Lease Exit Obligations
LongTermPortionOfLeaseExitObligations
6534000 USD
CY2011Q4 lgnd Long Term Portion Of Lease Exit Obligations
LongTermPortionOfLeaseExitObligations
8367000 USD
lgnd Maturity Period Of Cash And Cash Equivalents
MaturityPeriodOfCashAndCashEquivalents
three months or less
lgnd Maturity Period Of Highly Liquid Securities Maximum
MaturityPeriodOfHighlyLiquidSecuritiesMaximum
P3M
lgnd Maturity Period Of Short Term Investments
MaturityPeriodOfShortTermInvestments
more than three months
lgnd Maximum Period For Accounts Receivable Outstanding To Be Considered As Past Due
MaximumPeriodForAccountsReceivableOutstandingToBeConsideredAsPastDue
P90D
CY2012Q3 lgnd Minimum Investment Annually
MinimumInvestmentAnnually
1500000 USD
lgnd Minimum Period For Accounts Receivable Outstanding To Be Considered As Past Due
MinimumPeriodForAccountsReceivableOutstandingToBeConsideredAsPastDue
P30D
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
-1317000 USD
lgnd Non Cash Change In Estimated Fair Value Of Contingent Value Rights
NonCashChangeInEstimatedFairValueOfContingentValueRights
1191000 USD
lgnd Non Restricted Equity And Debt Securities With Maturity Period
NonRestrictedEquityAndDebtSecuritiesWithMaturityPeriod
P3M
lgnd Number Of Employees Required
NumberOfEmployeesRequired
5 employee
CY2011Q1 lgnd Number Of Fda Approved Medications
NumberOfFdaApprovedMedications
6 medications
CY2011Q1 lgnd Number Of Licensees
NumberOfLicensees
3 licensee
CY2012Q3 lgnd Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Maximum
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMaximum
0.035
CY2012Q3 lgnd Operating Leases Of Lessee Contingent Rentals Basis Spread On Variable Rate Minimum
OperatingLeasesOfLesseeContingentRentalsBasisSpreadOnVariableRateMinimum
0.03
CY2011Q4 lgnd Other Liabilities Other Immaterial Liabilities Not Separately Reported Noncurrent
OtherLiabilitiesOtherImmaterialLiabilitiesNotSeparatelyReportedNoncurrent
0 USD
CY2012Q3 lgnd Other Liabilities Other Immaterial Liabilities Not Separately Reported Noncurrent
OtherLiabilitiesOtherImmaterialLiabilitiesNotSeparatelyReportedNoncurrent
119000 USD
lgnd Payments To Contingent Value Right Holders
PaymentsToContingentValueRightHolders
USD
lgnd Payments To Contingent Value Right Holders
PaymentsToContingentValueRightHolders
8049000 USD
lgnd Percentage Of Contingent Consideration
PercentageOfContingentConsideration
0.2
CY2012Q3 lgnd Percentage Of Net Sales Payable As Royalty
PercentageOfNetSalesPayableAsRoyalty
0.065
lgnd Period Allowed For Return Of Products Maximum
PeriodAllowedForReturnOfProductsMaximum
P90D
lgnd Period Allowed For Return Of Products Minimum
PeriodAllowedForReturnOfProductsMinimum
P30D
lgnd Period For Which Available Resources Are Sufficient To Satisfy Anticipated Operating And Capital Requirements
PeriodForWhichAvailableResourcesAreSufficientToSatisfyAnticipatedOperatingAndCapitalRequirements
P12M
lgnd Revenue From Related Parties Current Percentage
RevenueFromRelatedPartiesCurrentPercentage
0.2
CY2012Q3 lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate
0.082
CY2011Q3 lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueForfeitureRate
0.088
lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Maximum Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMaximumForfeitureRate
0.112
lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Maximum Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMaximumForfeitureRate
0.141
lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Minimum Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMinimumForfeitureRate
0.080
lgnd Share Based Compensation Arrangement By Share Based Payment Award Fair Value Minimum Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueMinimumForfeitureRate
0.088
CY2011Q4 lgnd Short Term Portion Of Lease Exit Obligations
ShortTermPortionOfLeaseExitObligations
3208000 USD
CY2012Q3 lgnd Short Term Portion Of Lease Exit Obligations
ShortTermPortionOfLeaseExitObligations
2987000 USD
CY2012Q3 lgnd Working Capital
WorkingCapital
-12400000 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
dei Document Period End Date
DocumentPeriodEndDate
2012-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000886163
CY2012Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
19964456 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
LIGAND PHARMACEUTICALS INC

Files In Submission

Name View Source Status
0000886163-12-000060-index-headers.html Edgar Link pending
0000886163-12-000060-index.html Edgar Link pending
0000886163-12-000060.txt Edgar Link pending
0000886163-12-000060-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
lgnd-20120930.xml Edgar Link completed
lgnd-20120930.xsd Edgar Link pending
lgnd-20120930_cal.xml Edgar Link unprocessable
lgnd-20120930_def.xml Edgar Link unprocessable
lgnd-20120930_lab.xml Edgar Link unprocessable
lgnd-20120930_pre.xml Edgar Link unprocessable
lgnd-2012930x10q.htm Edgar Link pending
lgnd-ex311_2012930xq3.htm Edgar Link pending
lgnd-ex312_2012930xq3.htm Edgar Link pending
lgnd-ex321_2012930xq3.htm Edgar Link pending
lgnd-ex322_2012930xq3.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending